Kamada KMDA
NASDAQ KMDA
$8.21 -0.08 (-0.97%)
As of: Sep 9, 2026 · 3:59 PM EDT

Kamada (KMDA) Current Assets (2012 - 2026)

Kamada's (KMDA) quarterly Current Assets came in at $199.6 million in Q2 2026, up 8.9% on a YoY basis from $183.3 million in Q2 2025, and little changed quarter-over-quarter from $199.2 million in Q1 2026.

Analysis

Kamada (KMDA) Current Assets (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Current Assets for 13 consecutive years, with $199.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Current Assets rose 8.9% year-over-year to $199.6 million; the trailing twelve-month figure through Jun 2026 stood at $199.6 million (up 8.9% YoY), and the FY2025 full-year result was $193.1 million, up 4.73% from the prior year.
  • Current Assets was little changed at $199.6 million in Q2 2026 per KMDA's latest filing, from $199.2 million in the prior quarter.
  • Across five years, Current Assets topped out at $199.6 million in Q2 2026 and bottomed at $116.2 million in Q1 2022.
  • Historically, Current Assets has averaged $162.4 million across 5 years, with a median of $165.4 million in 2024.
  • The sharpest annual moves came in 2022 and 2024: Current Assets plunged 33.87% in 2022, then gained 28.33% in 2024.
  • Over 5 years, Current Assets stood at $139.0 million in 2022, then rose by 22.27% to $170.0 million in 2023, then advanced by 8.46% to $184.3 million in 2024, then rose by 4.73% to $193.1 million in 2025, then gained by 3.37% to $199.6 million in 2026.
  • According to Business Quant data, Current Assets over the past three periods registered $199.6 million, $199.2 million, and $193.1 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 34.96 Bn
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn 13.95 Bn
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 12.54 Bn
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 18.45 Bn
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 8.07 Bn
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn 5.82 Bn
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 4.62 Bn
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 7.31 Bn
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn 4.74 Bn
10 Kamada 473.57 Mn 403.43 Mn 22.47 Mn 199.57 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 199.57 Mn
Mar 31, 2026 199.24 Mn
Dec 31, 2025 193.08 Mn
Sep 30, 2025 192.73 Mn
Jun 30, 2025 183.27 Mn
Mar 31, 2025 188.50 Mn
Dec 31, 2024 184.35 Mn
Sep 30, 2024 164.41 Mn
Jun 30, 2024 166.43 Mn
Mar 31, 2024 157.81 Mn
Dec 31, 2023 169.96 Mn
Sep 30, 2023 153.15 Mn
Jun 30, 2023 129.68 Mn
Mar 31, 2023 131.40 Mn
Dec 31, 2022 139.01 Mn
Sep 30, 2022 135.16 Mn
Jun 30, 2022 118.60 Mn
Mar 31, 2022 116.16 Mn
Dec 31, 2021 130.04 Mn
Sep 30, 2021 178.94 Mn